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Human asparaginase 3 (hASNase3), which belongs
to the N-terminal nucleophile hydrolase superfamily,
is synthesized as a single polypeptide that is devoid
of asparaginase activity. Intramolecular autoproteo-
lytic processing releases the amino group of
Thr168, a moiety required for catalyzing asparagine
hydrolysis. Recombinant hASNase3 purifies as the
uncleaved, asparaginase-inactive form and un-
dergoes self-cleavage to the active form at a very
slow rate. Here, we show that the free amino acid
glycine selectively acts to accelerate hASNase3
cleavage both in vitro and in human cells. Other small
amino acids such as alanine, serine, or the substrate
asparagine are not capable of promoting autopro-
teolysis. Crystal structures of hASNase3 in complex
with glycine in the uncleaved and cleaved enzyme
states reveal the mechanism of glycine-accelerated
posttranslational processing and explain why no
other amino acid can substitute for glycine.
INTRODUCTION
The human genome codes for at least three enzymes capable
of hydrolyzing the amino acid asparagine to aspartate and
ammonia. The most-studied enzyme is the lysosomal aspartyl-
glucosaminidase (AGA), whose function is to remove carbohy-
drate groups linked to asparagine, as the final step in the
degradation of cell-surface glycoproteins (Oinonen et al.,
1995). Defects in AGA are the cause of aspartylglucosaminuria,
an inborn lysosomal storage disease (Saito et al., 2008). A
second enzyme is called 60 kDa lysophospholipase, which has
an N-terminal domain homologous to the E. coli type I asparagi-
nase (Sugimoto et al., 1998). The third enzyme, and the focus of
this work, is called L-asparaginase (also known as hASRGL1/
ALP [Bush et al., 2002] or CRASH [Evtimova et al., 2004]). Due
to the sequence and structural homology of this enzyme with
the E. coli type III asparaginase, we refer to this human aspara-
ginase as hASNase3. A member of the N-terminal nucleophile
(Ntn) family of hydrolases (Brannigan et al., 1995), this 308 resi-
due enzyme is produced as an inactive single polypeptide that
must undergo a peptide-bond break between residues Gly167
and Thr168 to attain asparaginase activity. Cleavage releases
the amino group of Thr168, and this endows the enzyme withChemistry & Biology 20,catalytic activity. This mechanism of protease activation is
different from that which occurs in proenzymes (zymogens)
such as trypsinogen, pepsinogen, thrombin, or caspases, where
the inactivating protein region is cleaved off, either through
another protease or through autoproteolysis, and then separates
from the now-active enzyme (Kassell and Kay, 1973; Wolan
et al., 2009). Importantly, the fold of Ntn family members is
unchanged after the cleavage reaction, with the N-terminal
(referred to as the a chain) and C-terminal (b chain) parts remain-
ing tightly associated to build a single functional unit. The cleav-
age reaction of Ntn hydrolases occurs autocatalytically, without
a need for proteases (Brannigan et al., 1995; Xu et al., 1999).
Expression of hASNase3 in normal human tissue, observed in
all developmental stages except neonate (based on the ex-
pressed sequence tags database), is restricted to a few organs
that include the testis, brain, esophagus, prostate, and prolifer-
ating endometrium (Bush et al., 2002; Weidle et al., 2009).
Interestingly, it has also been detected in several human tumors
(Weidle et al., 2009), but the implication or the role of hASNase3
in cancer biology is unknown. To increase our understanding of
this enzyme, we recombinantly expressed hASNase3, which
purified as the uncleaved form. Since the uncleaved enzyme is
catalytically inactive, we sought conditions that would promote
the transformation to the cleaved and active state. We report
that the free amino acid glycine highly selectively acts to promote
the autocleavage reaction of hASNase3 in a concentration-, tem-
perature-, and time-dependent manner. In addition, we present
crystal structures of hASNase3 in complex with glycine that pro-
vide a molecular basis for the glycine-induced autocleavage of
the enzyme. We propose that glycine-dependent activation of
hASNase3 is related to the alteredmetabolic profile of cells char-
acterized by increased glycolysis and reduced flux through the
tricarboxylic acid (TCA) cycle. Since de novo synthesis of aspar-
tate requires the TCA cycle intermediate oxaloacetate, such cells
can instead convert asparagine to aspartate using hASNase3.
Glycine, synthesized from the glycolysis metabolite 3-phospho-
glycerate via serine, would act as the sensor that regulates
cellular aspartate concentrations via hASNas3 activation.
RESULTS
Correlation between Glycine and hASNase3 Cleavage
Upon bacterial expression and purification, hASNase3 exhibited
a single 40 kDa band on SDS-PAGE corresponding to the
uncleaved form (Figure 1A). In contrast, when we purified the
homologous E. coli type III asparaginase, the predominant
form was the cleaved version that presents itself as two533–540, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 533
Figure 1. Self-Cleavage of hASNase3 Is Slow in the Absence of Glycine
(A) hASNase3 (4 mg/ml) was incubated in storage buffer at 25C or 37C, and samples were taken daily. Even after 3 days, the majority of the enzyme is still
uncleaved (top band). Cleaved protein runs as two separate bands of lower molecular weight, representing the a and b subunits. Percentage denotes uncleaved
band intensity relative to the sum of all forms (uncleaved + a + b).
(B) Schematic of the proposed cleavage reaction. A base (shown as B) would accept the proton from the hydroxyl group of Thr168. The identity of this base in the
case of hASNase3 was not known prior to this work.
(C) hASNase3 was incubated for 1 day at 25C at different pH values using appropriate buffers: citrate, pH 2.5–6.5; Tris, pH 7.5 and 8.5; Bicine, pH 9.0; TAPS, pH
9.5; glycine, pH 9.5 (red arrow); CAPS, pH 10.5. All buffers were at 100 mM. The enzyme sample prior to incubation is labeled 80C in all figures.
See also Figures S1 and S2.
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Activation of Human Asparaginase by Glycinelower-molecular-weight bands on a gel (data not shown). The
proportion of cleaved hASNase3 did increase gradually over
time, but even after 3 days, the uncleaved form constituted
70% of the protein incubated at 25C and54% of the protein
incubated at 37C (Figure 1A; Figure S1 available online). The
measured asparaginase activity of hASNase3 was proportional
to the amount of cleaved enzyme, indicating that only the
cleaved state was catalytically competent (data not shown).
The extremely slow and incomplete self-cleavage of hASNase3
is consistent with a previous report (Cantor et al., 2009), but is
different from observations made with bacterial (Borek and Jas-
ko´lski, 2000; Borek et al., 2004) and plant (Michalska et al., 2006)
asparaginases, which showed efficient autoproteolysis in vitro
even at 4C, with the bacterial enzyme being fully cleaved in
the first purification steps.534 Chemistry & Biology 20, 533–540, April 18, 2013 ª2013 ElsevierAnalogy to other studied Ntn family members (Michalska et al.,
2008) suggested that self-cleavage commences with the side
chain of Thr168 acting as a nucleophile that attacks the carbonyl
of Gly167 (Figure 1B, subpanel A). Note that the essential residue
Thr168 of hASNase3 plays a dual role. First, its side chain is
required for the cleavage reaction. Second, with the break of
the peptide bond between Gly167 and Thr168, the freed amino
group of Thr168 participates in catalyzing the hydrolysis of
asparagine. A base that would accept the proton from the
Thr168 hydroxyl group would accelerate the first step of the
cleavage reaction. In several Ntn enzymes, the side chain of an
aspartic acid residue prior to the scissile bond acts as this
base (Qian et al., 2003), but in hASNAse3 the residue preceding
Thr168 is a glycine. When replacing this glycine with aspartate in
hASNase3, no cleavage was detected (data not shown).Ltd All rights reserved
Figure 2. Increase in Extent of hASNase3 Cleavage Is Specifically Dependent on Glycine
(A) hASNase3 was incubated at 25C for 42 hr in storage buffer containing increasing glycine concentrations at pH 7.5. There is a glycine-dose-dependent
increase in the extent of cleavage. Percentage reflects quantification of uncleaved band intensity, with enzyme prior to incubation set at 100%.
(B) hASNase3was incubated at 25C in storage buffer supplemented with 10mMglycine, alanine, serine, or asparagine, and samples were taken daily for 3 days.
Quantification as in (A). In all conditions, the amount of cleaved hASNase3 slowly increases due to the intrinsic rate of autoproteolysis. However, only glycine
accelerates autocleavage beyond the intrinsic rate.
See also Figures S3, S4, S8, and S9.
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Activation of Human Asparaginase by GlycineInterestingly, the E. coli type III enzyme, like the human enzyme,
has a glycine residue preceding the cleavage site, yet it un-
dergoes self-cleavage efficiently (Borek et al., 2004). This points
to divergence in the mechanism of cleavage between Ntn family
members. After building the tetrahedral intermediate, water is
thought to act to complete the hydrolysis reaction (Figure 1B,
subpanel C). Due to the observation of very slow cleavage of
hASNase3 at physiological pH, we reasoned that a high pH
would promote deprotonation of the Thr168 hydroxyl, making
it more nucleophilic. However, incubation of hASNase3 in three
different buffers spanning the pH range of 9 to 10 showed no in-
crease in the cleaved form of the enzyme (Figure S2). When
repeating the pH-scanning experiment in a wider pH range
(from 2.5 to 10.5), all but one of the ten pH conditions tested
showed the single band of the uncleaved enzyme, whereas at
pH 9.5, using a glycine buffer, we observed essentially complete
cleavage of hASNase3 (Figure 1C, red arrow). The two lower-
molecular-weight bands of about 22 and 15 kDa observed with
glycine buffer correspond to residues 1–167 (a chain) and 168–
308 (b-chain), respectively, of the cleaved enzyme. This finding
was surprising since we had already tested this pH range and
saw no increase in cleavage (Figure S2). Indeed, the lane
adjacent to the glycine-treated sample (Figure 1C) contained
TAPS buffer at the same pH of 9.5, yet showed very little cleav-
age. This suggested that glycine, rather than simply the pH,must
play a critical role in promoting cleavage of hASNase3, poten-
tially as the base depicted in Figure 1B.
Next, we assessed the dependence of self-cleavage on the
glycine concentration and pH. Indeed, the extent of cleavage
was glycine-dose dependent (Figure 2A), and even the lowest
glycine concentration (5 mM) promoted 40% cleavage, a cleav-
age amount requiring 11 days in a buffer lacking glycine (Fig-
ure S1). Significantly, this glycine acceleration of hASNase3
cleavage occurs at the physiological pH of 7.5 nearly as effi-
ciently as at pH 9.5 (Figure S3). We wondered whether other
amino acids could function as cleavage accelerators. Since
this would presumably require the binding of the amino acid to
the active site of hASNase3, we reasoned that amino acids
with small side chains would have a greater chance of replacing
glycine. However, the addition of alanine or serine did not in-Chemistry & Biology 20,crease the proportion of cleaved enzyme above that obtained
by intrinsic cleavage (Figure 2B). Moreover, the substrate aspar-
agine also did not accelerate the cleavage rate beyond its
intrinsic rate. Likewise, small-molecule metabolites, such as gly-
colate, glyoxylate, sarcosine, oxalate, choline, or ethanolamine,
failed to trigger or inhibit the cleavage reaction (Figure S4).
We also examined the effects of these metabolites on the
asparaginase activity of the cleaved enzyme. Indeed, the cleav-
age-activator glycine, as well as some of these compounds at
relatively high concentration, inhibited the activated form of the
enzyme. While glycine at either 10 or 50 mM reduced asparagi-
nase activity by about 50%, glycolate, glyoxylate, oxalate,
L-aspartate, and serine showed a concentration-dependent
effect, lowering the catalytic activity by up to 5-fold at nonphy-
siological 50 mM (Figure S5). This demonstrates that several of
the tested compounds have the ability to bind to the enzyme
(at least to the cleaved form), but only glycine has the ability to
promote the cleavage reaction.
Structural Analysis of hASNase3
To understand the mechanism behind the glycine-induced
cleavage reaction, we solved the crystal structure of uncleaved
hASNase3 in complex with glycine. Our previous work on
hASNase3 (Nomme et al., 2012) revealed that, depending on
the age of our crystals, we can obtain the structure of either
the uncleaved (using fresh crystals) or cleaved state (using crys-
tals grown several months earlier). In those structures, we
observed a precipitant molecule (e.g., malonate, sulfate) occu-
pying the asparagine-binding site. In fact, due to competition be-
tween the precipitant and any added amino acid, in order to
obtain the hASNase3-ASP complex, we had to transfer the
crystals out of the precipitant and into a highly concentrated
ASP solution (Nomme et al., 2012). Based on this experience,
to obtain the uncleaved hASNase3-glycine complex, we used
freshly prepared crystals, whichwere transferred to a 3Mglycine
solution. The high glycine concentration was required to stabilize
the crystal in the absence of the precipitant and to supply the
glycine for complex formation. Despite using fresh crystals that
were exposed only shortly to a pH 7.5 glycine solution, diffraction
data revealed full hASNase3 cleavage. Based on the cleavage533–540, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 535
Table 1. Data Collection and Refinement Statistics
Complex GLY, pH 4.9 GLY, pH 3.3
Protein Data Bank codes 4HLP 4HLO
X-ray source and detector SERCAT BM SERCAT ID
MARCCD 225 MARCCD 300
Wavelength (A˚) 1.0 1.0
Temperature (K) 100 100
Resolutiona (A˚) 1.91 (1.91–2.02) 1.95 (1.95–2.0)
Number of reflections
Observed 144,084 425,284
Unique 45,006 43,500
Completeness (%) 95.7 (81.7) 98.2 (90.0)
Rsym (%) 5.5 (37.9) 12.5 (51.2)
I/s(I) 12.40 (1.55) 12.70 (2.12)
Space group P 65 P 65
Unit cell (A˚)
a = b 59.74 59.94
c 301.53 301.10
Refinement program REFMAC5 REFMAC5
Twinning fraction 0.514 0.505
Refinement statistics
Rcryst (%) 18.4 16.7
Rfree (%) 22.4 20.9
Resolution range (A˚) 30 - 1.91 30 - 1.95
Protein molecules per a.u. 2 2
Number of atoms
Protein 2,158, 2,158 2,196, 2,199
Glycine 5 3 4 5 3 5
Water 181 176
Rmsd
Bond length (A˚) 0.009 0.011
Bond angles () 1.116 1.354
Average B-factors (A˚2) /chain
Protein 31, 32 24, 24
Glycine 34 33
Water molecules 32 23
Ramachandran plot
Most favored regions (%) 92.2 88.5
Additionally allowed regions (%) 7.2 10.5
Generously allowed regions (%) 0.2 0.6
Disallowed regions (%) 0.4 0.4
aLast shell in parentheses.
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Activation of Human Asparaginase by Glycinemechanism (Figure 1B), we reasoned that a lower pH and
an even shorter soak time would allow us to trap the enzyme
in its precleaved state, the state relevant for probing the
glycine-induced cleavage reaction. Yet again, a data set
(1.91 A˚ resolution; Table 1) collected from a crystal soaked in
3 M glycine (pH 4.9) for <1 min showed full protein cleavage
(Figure 3A). In this postcleavage state of hASNase3, glycine
bound at the active site very similarly to the product aspartate
(Nomme et al., 2012), forming interactions with the conserved536 Chemistry & Biology 20, 533–540, April 18, 2013 ª2013 Elsevierresidues Arg196 via its carboxylic acid moiety and Asp199 via
its amino group (Figure 3B). The sole interaction with Thr168
occurs between the glycine amino group and the hydroxyl moi-
ety of Thr168 (3.3 A˚). This glycine-binding mode failed to clarify
how the amino acid would act to accelerate peptide cleavage
between Gly167 and Thr168.
The observation of a fully cleaved enzyme state in the pH 4.9
soaked crystal prompted us to test an even lower pH. Indeed,
by soaking a crystal of hASNase3 in a glycine solution of pH
3.3, we successfully obtained the complex in the precleaved
enzyme state (Figure 3C). For the uncleaved enzyme, we could
model the entire polypeptide chain except four residues that
span Gln158 and Gln163. The electron density of the scissile
bond between Gly167 and Thr168 clearly shows an intact pep-
tide bond (Figure 3D). In this complex structure, solved at
1.95 A˚ resolution, we again observed the previously mentioned
glycine molecule at the substrate-binding site, making very
similar interactions as noted in the pH 4.9 structure (labeled
GLY1 in Figure 3C). Unexpectedly, an additional glycine mole-
cule occupied the active site (labeled GLY2 in Figures 3C and
S6), this time spanning the conserved threonines at positions
168 and 219. Notably, the carboxylic acid group of this second
glycine is at only 2.6 A˚ distance to the hydroxyl of the catalytically
essential Thr168. This type of interaction would allow GLY2 to
act as the base that accepts the proton from the Thr168 hydroxyl
group, thereby activating it to attack the carbonyl group of the
preceding residue, Gly167. We analyzed the binding site of
GLY2 in the hASNase3 active site in order to understand why
no other amino acid could substitute for glycine in promoting
cleavage (Figure 2B). Modeling of alanine in place of GLY2 re-
veals a steric clash between the methyl side-chain and main-
chain atoms of hASNase3 (Figure S7). This rationalizes why
even the next-smallest amino acid, alanine, would be sterically
excluded from the GLY2 binding site, and hence the cleavage-
promoting specificity of glycine. It is of interest to mention here
that the dipeptide glycylglycine does not induce (Figure S4) or
inhibit autocleavage (Figure S8) or affect the asparaginase activ-
ity of the activated enzyme (Figure S5), suggesting that glycylgly-
cine lacks the ability to bind to the hASNas3 active site.
Glycine Promotes hASNase3 Cleavage in Human Cells
We next asked whether glycine-accelerated cleavage, and
hence activation, also occurs in mammalian cells. HEK293 cells
were transiently transfected with the hASNase3 gene, and
hASNase3 expression level and molecular state were monitored
using western blot analysis (Figure 4). Cells grown in regular me-
dia, without glycine supplementation, predominantly expressed
uncleaved hASNase3 (Figure 4). Note that themedia used for the
cell culture experiments contained 135 mM glycine, not taking
into account any glycine coming from the fetal bovine serum.
This explains the low, but not absent, cleavage of hASNase3 in
this condition. The addition of an extra 1mMglycine to themedia
resulted in a more than 25% reduction of uncleaved protein with
a concomitant increase in the cleaved forms. Higher concentra-
tions of glycine promoted progressively increased protein cleav-
age, such that at 5 mM added glycine, less than 10% remains in
the uncleaved state, with approximately complete cleavage
occurring at higher glycine concentrations after the same incu-
bation time.Ltd All rights reserved
Figure 3. hASNase3 Structure in Complex with
Glycine
(A) The cleaved state of the homodimeric enzyme, obtained
from crystals soaked in a 3 M glycine solution, pH 4.9, is
depicted. One protomer is colored in dark and light blue, and
the other in dark and light gray. The dark and light shades
depict the a and b chains, respectively. The glycine bound at
the active site is depicted as a space-filling object. The black
star denotes the most C-terminal residue of the a chain with
traceable electron density, and the red star denotes the
N-terminal residue of the b chain, which is Thr168.
(B) Active-site residues in the cleaved hASNase3-GLY
complex structure at pH 4.9. Gray arrow denotes the free
amino group of Thr168 resulting from cleavage. Glycine
binds in a similar fashion to aspartate (green; as seen in the
hASNase3-ASP complex structure; Protein Data Bank code
4GDW). Distances are in angstroms.
(C) The uncleaved hASNase3-GLY complex structure at pH
3.3. Two free glycine molecules are present at the active
site. Glycine 1 (GLY1) binds in the same position as the
glycine in (B), and glycine 2 (GLY2) binds in proximity to
the scissile bond. Importantly, GLY2 interacts directly with
the Thr168 OH group via its carboxylic acid moiety (2.6 A˚). It
is this interaction that can serve to activate Thr168 to attack
the carbonyl group of Gly167.
(D) The Fo-Fc omit map contoured at the 3 sigma level
displays the uncleaved peptide bond. To avoid model bias,
residues 163 to 168 were omitted from the model, which
then underwent multiple refinement rounds. The difference
electron density map reveals the conformation of Thr168
and of the residues that precede it. This region, despite
being uncleaved, seems to have increased mobility relative
to the core structure. As a result, some side-chain densities
(e.g., Leu166, Asn165) are not contiguous but clearly pre-
sent. The increased mobility of this region was also
observed in the structures of hASNase3mutants that cannot
undergo cleavage (data not shown). A gray arrow points to
the peptide bond that breaks as hASNase3 is cleaved into
the a and b chains.
See also Figures S6 and S7.
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Here, we report that physiologically relevant glycine concentra-
tions can dramatically accelerate, and drive to completion, the
weak intrinsic self-cleavage reaction of hASNase3. While we
do find that millimolar glycine levels are required for efficient
cleavage (Figure 4), concentrations between 3 and 8 mM (de-Chemistry & Biology 20, 533–540, April 1pending on the tissue examined) have been
measured in vivo (Pitka¨nen et al., 2003). Remark-
ably, the most recent work, which examined the
role of the pyruvate kinase isoform M2 (PKM2)
in regulating glycolytic flux in cancer cells and
the dependence of PKM2 activity on serine and
glycine biosynthesis, revealed intracellular accu-
mulation of free glycine of up to 10mM (Chaneton
et al., 2012), a concentration that would promote
complete cleavage of hASNase3 (Figure 4).
Glycine did not activate PKM2 in cells or in vitro,
yet this work demonstrated serine as the only
amino acid to do so in vitro, with this finding being
further substantiated by structural analyses ofPKM2-serine complexes (Chaneton et al., 2012). In the case of
hASNase3, we discovered a specific role of glycine in activating
the enzyme both in vitro and in cells. This prompts the following
questions: What is the relevance of glycine levels in cells to
hASNase3’s in vivo function, specifically to any potential role
of glycine as a regulator of hASNase3 activity? Can we ratio-
nalize its expression pattern in normal tissue and in several8, 2013 ª2013 Elsevier Ltd All rights reserved 537
Figure 4. Glycine Promotes hASNase3 Cleavage in Human Cells
(A) Western blot of HEK293 cells transfected with the gene for hASNase3, grown in regular media or in media supplemented with the noted glycine levels for
2 days. Detection of the hASNase3 state was done using polyclonal antibodies raised against the full-length protein. Antibodies detect well the uncleaved enzyme
and the a subunit, but give only a weak signal for the b subunit. The uncleaved (Un-cl) and cleaved (cl) human enzyme purified from E. coli is shown for reference.
Protein loading control is shown below.
(B) Quantification of the uncleaved band, with the condition of no glycine supplementation set at 100%.
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Activation of Human Asparaginase by Glycinehuman tumors? We note that hASNase3 has dual asparaginase
and isoaspartyl peptidase activities (isoaspartyl peptide linkages
are a common source of protein damage; Aswad et al., 2000),
with seemingly similar kinetic efficiencies (Cantor et al.,
2009). This causes ambiguity as to the precise physiological
function of hASNase3. In this context, it is worth recalling that
human AGA also has dual catalytic function, hydrolyzing
b-aspartyl-glucosamine linkages in glycoproteins and various
b-aspartyl-amides, including asparagine itself. Moreover, the
threonine aspartase Taspase1 acts as an endopeptidase that
cleaves the mixed-lineage leukemia protein (Hsieh et al., 2003),
the basal transcription factor TFIIA (Hsieh et al., 2003), and other
intracellular substrates after an aspartate residue in the recogni-
tion sequence (Bier et al., 2011). Like hASNase3, these enzymes
belong to the Ntn-hydrolase protein family where the full-length
enzymes undergo posttranslational autoproteolytic processing,
liberating the N-terminal threonine of the b subunit as the cata-
lytic nucleophile. This threonine residue has been shown by
mutational analyses to act as the nucleophile for both autopro-
teolysis and hydrolase activity. While several residues critical
for self-cleavage have been identified in human AGA (Bier
et al., 2011), no regulatory, or triggering, factor is known for
this intramolecular activation step. In contrast, in the case of
hASNase3, our work reveals that free glycine very selectively
triggers this activation process, which suggests a link to physio-
logical situations of increased glycine levels.
In the physiological context, one intriguing possibility relates
to situations where intracellular glycine levels are increased
with a concomitant decrease in aspartate levels. This metabolic
imbalance is observed in cancer cells where altered gene
expression increases the flux through glycolysis (Warburg,
1956). One enzyme implicated in increased glycolysis is PKM2,
which is detected in cancer cells and replaces the catalytically
more efficient M1 isoform (Vander Heiden et al., 2009). The
consequence of reduced pyruvate kinase activity is closure of
the spigot connecting the glycolytic pathway to the TCA cycle.538 Chemistry & Biology 20, 533–540, April 18, 2013 ª2013 ElsevierThis allows for the diversion of glycolysis intermediates for the
synthesis of essential metabolites. In fact, it was recently shown
that a small-molecule activator of PKM2 induces serine auxot-
rophy, an amino acid whose synthesis relies on the glycolytic
intermediate 3-phosphoglycerate (Kung et al., 2012). A second
enzyme involved in diverting glycolytic intermediates into serine
biosynthesis is phosphoglycerate dehydrogenase, and this ac-
tivity has also been proposed to contribute to cancer cell prolif-
eration (Locasale et al., 2011). As glycine is generated from
serine, increased glycolytic flux would increase the glycine
levels, as demonstrated by studies of a cancer cell line (Locasale
et al., 2011) and brain tumors in vivo (Maher et al., 2012). A recent
metabolite-profiling study of NCI-60 cancer cell lines correlated
glycine levels with proliferation rates, showcasing the important
role of this amino acid in rapidly dividing cells (Jain et al., 2012).
At the same time, increased glycolytic flux reduces the flow
of metabolites to the TCA cycle. Reduced TCA flux limits the
synthesis of molecules that originate from TCA intermediates.
One specific example of such a molecule is the amino acid
aspartate, whose de novo synthesis requires the TCA intermedi-
ate oxaloacetate. Indeed, a marked decrease in the level of the
amino acid aspartate was observed in rat brain gliomas (Ziegler
et al., 2001). The data we present here suggest that one mecha-
nism used by cells to counter low TCA flux is to activate the
enzyme hASNase3, which then provides the required aspartic
acid by catalyzing asparagine hydrolysis. Thus, activation of
hASNase3 by glycine would compensate for the lack of aspar-
tate by converting asparagine to aspartate.
Thus, we suggest a model where cancer cells usurp a regula-
tory mechanism (i.e., dependency of hASNase3 activation on
glycine levels) that pre-exists in noncancer cells (see below)
that normally express hASNase3 for the purpose of maintaining
the required metabolic balance. This model, which relates the
activity of metabolic enzymes to metabolite levels in order to
compensate for the altered metabolic requirements of rapidly
dividing cells, implies that inhibitors of such enzymes (e.g.,Ltd All rights reserved
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Activation of Human Asparaginase by GlycinehASNase3) could be explored as potential cancer therapeutics.
In fact, the targeting of enzymes that supply asparagine, in order
to limit cancer cell proliferation, is currently being explored by in-
hibiting asparagine synthetase (Richards and Kilberg, 2006). We
examined additional metabolites other than glycine that are
increased in glycolytic cells, such as pyruvate and lactate, but
these failed to recapitulate glycine’s ability to accelerate hAS-
Nase3 cleavage (Figure S9), highlighting the glycine specificity
of this process.
Finally, the cancer implications of hASNase3 raise questions
on its role in normal cells and the properties of these normal cells
vis-a`-vis glycine and aspartate concentrations. Consistent with
our model, it has been reported that normal brain (Coles et al.,
2000) and testis (Liu et al., 2011), two organswith high hASNase3
expression, have increased glycolytic activity. Additionally,
protein analyses of sperm extracts (Bush et al., 2002) revealed
hASNase3 in the predominately cleaved form, thereby corre-
lating the cleaved state of the enzyme with high glycine levels.
Further studies that probe the levels of amino acids in normal
and diseased states, and the cellular response to these changes,
are warranted.
SIGNIFICANCE
Human asparaginase 3 is an Ntn-family hydrolase requiring
cleavage between Gly167 and Thr168 for enzymatic activ-
ity. Autoproteolysis of recombinantly produced hASNase3
is very slow. We discovered that the free amino acid
glycine dramatically increases the rate and extent of
cleavage. Other amino acids or various small-molecule
metabolites tested in vitro are not capable of promoting
self-cleavage. The crystal structure of uncleaved hASNase3
in complex with glycine explains the ability of the amino
acid to promote this intramolecular reaction. We observe
two glycine molecules bound at the active site. The first
binds at the same position as the substrate asparagine.
The second glycine is positioned such that its carboxylic
acid moiety is in close proximity to the Thr168 hydroxyl
group. The latter binding mode would allow glycine to act
as a base that activates the hydroxyl group to attack the
carbonyl group of the preceding Gly167, thereby initiating
the cleavage reaction. The enzyme has limited expression
in normal tissue, being confined mainly to the testis and
brain. Notably, it has also been detected in several cancers.
A unifying feature of tissues that express hASNase3 is high
glycolytic level. Increased flux through glycolysis would
promote glycine synthesis, as it is generated from the
glycolysis metabolite 3-phosphoglycerate via serine. At
the same time, aspartate levels would be decreased, as
de novo synthesis of this amino acid requires the TCA cycle
intermediate oxaloacetate. Together, this implies that the
function of hASNase3 is to increase the level of aspartate
as compensation for its reduced synthesis and that the en-
zyme’s activity is regulated by the glycine concentration.
The requirement of highly glycolytic cells, such as those
found in cancers, to generate sufficient levels of key
metabolites, such as aspartate, suggests that molecules
inhibiting hASNase3 may act to reduce cancer cell
proliferation.Chemistry & Biology 20,EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Human ASNase3
The cloning and expression of hASNase3 have been reported previously
(Nomme et al., 2012). In short, E. coli BL21(DE3) C41 carrying a modified
pET14b to include a SUMO tag was grown at 37C. Upon reaching an optical
density of 0.6–0.8, the temperature was reduced to 18C and 0.5 mM IPTG
was added to induce expression. After cell lysis by sonication, the enzyme
was purified using a metal affinity column and the SUMO tag was cleaved
by SUMO protease, followed by gel filtration. The fractions containing
hASNse3 were concentrated to 38 mg/ml, aliquoted, and stored at 80C.
Crystallization of hASNase3
A total of 1 ml of hASNase3 at 38 mg/ml (in 25 mM Tris [pH 7.5], 200 mM NaCl,
2 mM DTT) was mixed with 1 ml of the reservoir solution (2.2 M sodium malo-
nate) on a glass coverslip and left to undergo vapor diffusion using the hanging
dropmethod at 20C. To form the glycine complex, a crystal was transferred to
a 3 M glycine, pH 7.5 solution. Diffraction data on this crystal revealed the
cleaved state of the enzyme and a glycinemolecule at the active site. To obtain
a complex with the uncleaved enzyme, glycine solutions of lower pH were
tested. At pH 4.9, crystals of the cleaved formwere obtained (identical to those
soaked at pH 7.5). However, soaking at pH 3.3 yielded crystals with the un-
cleaved protein.
Data Collection and Structure Solution of hASNase3
Diffraction data were collected at the Advanced Photon Source (APS) located
at Argonne National Laboratory, using the SERCAT beamlines (see Table 1 for
data collection and refinement statistics). The structures were refined with
Refmac5 (Murshudov et al., 1997). All crystals were perfectly twinned, with
the true space group being P65 (apparent space group, P6522) and contained
two copies of hASNase3 (that is, an ab dimer) in the asymmetric unit. Refine-
ment using the twin option in Refmac5 showed a twin domain fraction of
50%. Data collected for freshly grown crystals showed the uncleaved state
of the enzyme, whereas in older crystals the enzyme was in the cleaved state.
Attempts to soak in the product aspartate (ASP) or glycine (GLY), even at a
concentration of 100 mM, failed to reveal electron density for these amino
acids. We interpret this as being due to competition by the precipitant salt.
To obtain the GLY complex, we transferred the crystals to a 3 M glycine
solution. The rationale was that a high concentration of glycine would act as
a precipitant to keep the crystals stable (attempts to transfer the crystals to
a nonsalt condition such as PEG were unsuccessful) and would also supply
the GLYmolecule bound at the active site. Diffraction data collected on a crys-
tal soaked in 3 MGLY pH 7.5 revealed the fully cleaved state (data not shown).
The same result was obtained with a crystal soaked in 3 M GLY, pH 4.9. In
contrast, we observed the uncleaved state in a crystal soaked in 3 M GLY,
pH 3.3.
For the cleaved pH 4.9 hASNase3-GLY complex (described here), we could
model residues 1 to 153 of the a chain (no traceable density for residues
154–167) and 168–308 of the b chain. For the uncleaved pH 3.3 GLY complex,
we could model all residues except 158–163. The electron density for the
residues immediately preceding the cleavage site was unambiguous (Fig-
ure 3D). All structure figures were made with PyMol.
Western Blot Experiments
HEK293 cells, grown in RPMI 1640 supplemented with 10% fetal bovine
serum, were transfected to express hASNase3, and cell lysates were analyzed
by western blots. All SDS-PAGE gel band intensities were quantified using
ImageJ. Polyclonal antibodies against hASNase3 were generated by immu-
nizing rabbits with 0.6 mg of SDS-PAGE-purified full-length protein according
to the Eurogentec (Seraing, Belgium) custom antibody production protocol.
For expressing and analyzing the enzyme in a human cell line, the gene coding
for hASNase3 was transferred from the pET14b vector to a pcDNA3.1()
(Invitrogen) with the addition of a Kozak sequence. HEK293 cells (3 3 106)
were grown to 90%–95% confluency and then transfected using Lipofect-
amine 2000 (Invitrogen). At this point, glycine at various concentrations was
added to the media. Cells were then incubated at 37C with 5% CO2. After
2 days, cells were harvested and lysates analyzed by western blots. Loading
controls were done using a tubulin antibody.533–540, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 539
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The structures of hASNase3 have been deposited in the Protein Data Bank
under accession codes 4HLP (GLY pH 4.9) and 4HLO (GLY pH 3.3).
SUPPLEMENTAL INFORMATION
Supplemental Information includes nine figures and can be found with this
article online at http://dx.doi.org/10.1016/j.chembiol.2013.03.006.
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